Previous Article | Next Article 
Journal of Virology, May 2001, p. 4705-4712, Vol. 75, No. 10
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.10.4705-4712.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Induction of pRb Degradation by the Human
Papillomavirus Type 16 E7 Protein Is Essential To Efficiently Overcome
p16INK4a-Imposed G1 Cell Cycle Arrest
Marianna
Giarrè,
Sandra
Caldeira,
Ilaria
Malanchi,
Francesca
Ciccolini,
Maria
João
Leão, and
Massimo
Tommasino*
Angewandte Tumorvirologie, Deutsches
Krebsforschungszentrum, D-69120 Heidelberg, Germany
Received 16 November 2000/Accepted 26 February 2001
It has previously been shown that the E7 protein from the cutaneous
human papillomavirus type 1 (HPV1), which is associated with benign
skin lesions, binds the product of the tumor suppressor gene
retinoblastoma (pRb) with an efficiency similar to that of the E7
protein from the oncogenic HPV type 16. Despite this ability, HPV1 E7
does not display any activity in transforming primary cells. In
addition, the two viral proteins differ in their mechanisms of
targeting pRb. HPV16 E7 promotes pRb destabilization, while cells
expressing HPV1 E7 do not show any decrease in pRb levels. In this
study, we show that HPV1 E7, in contrast to HPV16 E7, has only a weak
activity to neutralize the effect of cyclin-dependent kinase inhibitor
p16INK4a. By generation of HPV1/16 E7 chimeric proteins, we
have identified a central motif in the two E7 proteins, which
determines their different abilities to overcome the
p16INK4a-mediated cell cycle arrest. This motif is located
downstream of the pRb-binding domain and comprises only three amino
acids in HPV16 E7. Swapping this central motif in the two viral
proteins causes an exchange of their activities involved in
circumventing the inhibitory function of p16INK4a. Most
importantly, our data show that the efficiency of the E7 proteins in
neutralizing the inhibitory effect of p16INK4a correlates
with their ability to promote pRb degradation.
*
Corresponding author: Angewandte Tumorvirologie,
Deutsches Krebsforschungszentrum, INF 242, D-69120 Heidelberg, Germany.
Phone: 49 6221 424945. Fax: 49 6221 424932. E-mail:
M.Tommasino{at}DKFZ-Heidelberg.DE.

Present address: Laboratory of Clinical Chemistry, Lausanne
University Hospital (CHUV), CH-1011 Lausanne,
Switzerland.

Present address: Centre for Brain Repair, Forvie Site, Cambridge
CB2 2PY, United
Kingdom.
Journal of Virology, May 2001, p. 4705-4712, Vol. 75, No. 10
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.10.4705-4712.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Caberg, J.-H. D., Hubert, P. M., Begon, D. Y., Herfs, M. F., Roncarati, P. J., Boniver, J. J., Delvenne, P. O.
(2008). Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis
29: 1441-1447
[Abstract]
[Full Text]
-
Genovese, N. J., Banerjee, N. S., Broker, T. R., Chow, L. T.
(2008). Casein Kinase II Motif-Dependent Phosphorylation of Human Papillomavirus E7 Protein Promotes p130 Degradation and S-Phase Induction in Differentiated Human Keratinocytes. J. Virol.
82: 4862-4873
[Abstract]
[Full Text]
-
Santer, F. R., Moser, B., Spoden, G. A., Jansen-Durr, P., Zwerschke, W.
(2007). Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor-binding protein-3 by enhancing its ubiquitin/proteasome-dependent degradation. Carcinogenesis
28: 2511-2520
[Abstract]
[Full Text]
-
Branca, M, Giorgi, C, Ciotti, M, Santini, D, Di Bonito, L, Costa, S, Benedetto, A, Bonifacio, D, Di Bonito, P, Paba, P, Accardi, L, Mariani, L, Ruutu, M, Favalli, C, Syrjanen, K, on behalf of the HPV-Pathogen Istituto Superiore d,
(2006). Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer. J. Clin. Pathol.
59: 1044-1051
[Abstract]
[Full Text]
-
Zhang, B., Chen, W., Roman, A.
(2006). The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc. Natl. Acad. Sci. USA
103: 437-442
[Abstract]
[Full Text]
-
Branca, M, Giorgi, C, Santini, D, Di Bonito, L, Ciotti, M, Benedetto, A, Paba, P, Costa, S, Bonifacio, D, Di Bonito, P, Accardi, L, Favalli, C, Syrjanen, K, on behalf of the HPV-Pathogen ISS Study Group,
(2006). Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J. Clin. Pathol.
59: 40-47
[Abstract]
[Full Text]
-
Malanchi, I., Accardi, R., Diehl, F., Smet, A., Androphy, E., Hoheisel, J., Tommasino, M.
(2004). Human Papillomavirus Type 16 E6 Promotes Retinoblastoma Protein Phosphorylation and Cell Cycle Progression. J. Virol.
78: 13769-13778
[Abstract]
[Full Text]
-
Marchini, A., Marttila, T., Winter, A., Caldeira, S., Malanchi, I., Blaschke, R. J., Hacker, B., Rao, E., Karperien, M., Wit, J. M., Richter, W., Tommasino, M., Rappold, G. A.
(2004). The Short Stature Homeodomain Protein SHOX Induces Cellular Growth Arrest and Apoptosis and Is Expressed in Human Growth Plate Chondrocytes. J. Biol. Chem.
279: 37103-37114
[Abstract]
[Full Text]
-
Bechtold, V., Beard, P., Raj, K.
(2003). Human Papillomavirus Type 16 E2 Protein Has No Effect on Transcription from Episomal Viral DNA. J. Virol.
77: 2021-2028
[Abstract]
[Full Text]
-
Caldeira, S., Zehbe, I., Accardi, R., Malanchi, I., Dong, W., Giarre, M., de Villiers, E.-M., Filotico, R., Boukamp, P., Tommasino, M.
(2003). The E6 and E7 Proteins of the Cutaneous Human Papillomavirus Type 38 Display Transforming Properties. J. Virol.
77: 2195-2206
[Abstract]
[Full Text]
-
Hwang, S. G., Lee, D., Kim, J., Seo, T., Choe, J.
(2002). Human Papillomavirus Type 16 E7 Binds to E2F1 and Activates E2F1-driven Transcription in a Retinoblastoma Protein-independent Manner. J. Biol. Chem.
277: 2923-2930
[Abstract]
[Full Text]